Pharmacy Question for the Week of October 1, 2018

Pharmacy Compliance Question of the Week

Question:

When do the new level II codes Q5108 and Q5110 take effect?

Answer:

The effective date for code Q5108–injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg—is July 12, 2018. For Q5110–injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram—the effective date is October 1, 2018. The implementation date for both codes is October 1, 2018. This information can be found at https://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/2018Downloads/R4134CP.pdf.

Disclaimer: Every reasonable effort was made to ensure the accuracy of this information at the time it was published. However, due to the nature of industry changes over time we cannot guarantee its validity after the year it was published.